S. Radovanović

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial

Jozef Bartúnek, André Terzic, Beth A. Davison et al. · European Heart Journal · 2016 · 183 citations · Full text

Medicine, Cardiology, Cell Biology +13

Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

Marco Canepa, Cândida Fonseca, Cécile Laroche et al. · JACC Heart Failure · 2018 · 156 citations · Full text

Medicine, Cardiology, Clinical Cardiology +16

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 122 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Teleseismic tomography of the mantle in the Carpathian-Pannonian region of central Europe

Ben Dando, G. W. Stuart, G. A. Houseman et al. · Geophysical Journal International · 2011 · 107 citations · Full text

Natural Sciences, Earth Sciences, Geophysics +17